Regulon

Regulon: R-763

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
5-1.9808615Pr-57Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
22997 ENSG00000080854 IGSF9B Q9UPX0
23067 ENSG00000139718 SETD1B Q9UPS6
8019 ENSG00000169925 BRD3 Q15059
1995 ENSG00000196361 ELAVL3 Q14576
51621 ENSG00000275746 KLF13 Q9Y2Y9

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
RO-6870810BRD4Small moleculeINHIBITORBromodomain and extra-terminal motif (BET) inhibitor10
MOLIBRESIBBRD4Small moleculeINHIBITORBromodomain and extra-terminal motif (BET) inhibitor20
BIRABRESIBBRD4Small moleculeINHIBITORBromodomain and extra-terminal motif (BET) inhibitor22
BMS-986158BRD4Small moleculeINHIBITORBromodomain and extra-terminal motif (BET) inhibitor10
CPI-0610BRD4Small moleculeINHIBITORBromodomain and extra-terminal motif (BET) inhibitor30
APABETALONEBRD4Small moleculeINHIBITORBromodomain and extra-terminal motif (BET) inhibitor30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-763

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-11506OR2T6down-regulatesTRIM28activatesR-76371Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

RO-6870810, MOLIBRESIB, BIRABRESIB, BMS-986158, CPI-0610, APABETALONE

CMF-21736COL1A2up-regulatesTRIM28activatesR-76373Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

RO-6870810, MOLIBRESIB, BIRABRESIB, BMS-986158, CPI-0610, APABETALONE

CMF-26055MST1P9up-regulatesTRIM28activatesR-76372Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

RO-6870810, MOLIBRESIB, BIRABRESIB, BMS-986158, CPI-0610, APABETALONE

CMF-29566ESRRBdown-regulatesTRIM28activatesR-76375Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

RO-6870810, MOLIBRESIB, BIRABRESIB, BMS-986158, CPI-0610, APABETALONE

CMF-30133PRKDCup-regulatesTRIM28activatesR-76371Drugs (6)

Regulator Drugs (0)

Regulon Drugs (6)

RO-6870810, MOLIBRESIB, BIRABRESIB, BMS-986158, CPI-0610, APABETALONE